23-Year-Old Complains About Antidepressants: „My clitoris is completely numb.“

Erectile dysfunction and other sexual problems caused by and following the use of antidepressants

(The original German version of this post can be found here.)

In the first part, we examined historical and current trends in depression. The condition is primarily characterized by a lack of motivation and a depressed mood. Other difficulties may also arise, such as sleep disturbances, weight changes, and problems concentrating. We saw that depression is strikingly common and has been diagnosed with increasing frequency in recent years.

The second part focused on how psychotropic medications—which are frequently prescribed for depression—work. Since these drugs are often prescribed for other conditions as well—such as anxiety, eating, and obsessive-compulsive disorders—and their effects are not specifically antidepressant, the term “antidepressants” is actually misleading. For this reason, leading experts in pharmacology now recommend the terms “serotonin enhancers” or “norepinephrine enhancers.”

Although more than 2 billion daily doses of these medications are now prescribed in Germany each year—enough to treat 5.5 million people daily —their therapeutic effect is modest. Compared to a placebo, there is often only a slight improvement, if any at all. Recent studies suggest that when treating depression with psychotherapy, the use of psychotropic drugs offers no additional benefit. We also saw this in the second part.

What these substances do in the body is still not fully understood. Their effects appear to be, most likely, a combination of behaviorally activating and emotionally dampening effects. On the other hand, there are side effects such as emotional numbness, weight gain, and—especially among younger people—even an increased risk of suicide, as well as the frequently cited sexual dysfunction.

We will examine the latter in greater detail in this part. First, however, I would like to quote a depression expert from the field of psychiatry to support my critical perspective.

Psychiatric expert on depression

Many people have likely received different information from their doctor about the effects of “antidepressants.” That’s why it’s helpful to hear from a recognized expert on depression here. Fittingly, Gregor Hasler, a professor of psychiatry at the University of Fribourg (Switzerland), was a guest on the German “Swisslectures” podcast on June 7. The episode focused on “What Science Really Knows About Antidepressants.” A telling excerpt regarding the effects of psychotropic drugs was:

Hasler: “In an acute situation, the family doctor often just wants to manage the symptoms, and the patient is fine with that.” Host: “So in this case, it dampens everything.” Hasler: “It dampens everything a little bit, and then the patient is calmer and doesn’t keep calling. But for the patient, in an acute case, that can…” Host: “An easy solution for the family doctor.” Hasler: “Exactly. Generally speaking, family doctors love sedative medications and avoid stimulants. Otherwise, the patient might perk up and [he laughs] want even more appointments!—No, I don’t mean to make fun of that. I’m just saying that in an acute situation, sedation can be helpful, but you’re right—if you do that long-term, it’s not good.” … In the U.S., stimulating substances would be prescribed more often. “That also has to do with cultural differences. But yes, you see this with other medications as well—sedation is typically something used in nursing homes, where non-experts largely sedate the patients.” (Gregor Hasler, Swisslectures, June 7, 2026, approx. 25:30 and 30:30 minutes)

So while those affected are often told that they have a medical condition—namely, depression—linked to a neurotransmitter disorder in the brain, Hasler paints a different picture: “Antidepressants” are primarily prescribed to dampen emotions. This would have the advantage for doctors’ offices and nursing homes that patients would not call too often or request too many appointments.

The diagnosis, professor Hasler explains, is often made after just ten minutes, since that’s usually all the time you have with your family doctor. But not everyone affected would be comfortable talking about themselves for an hour, as might be the case during a psychiatric appointment.

Anxiety or depression?

The professor also wonders why serotonin enhancers—which are frequently prescribed as antidepressants—are considered treatments for depression at all, rather than as anxiety treatments. An answer to his question can be found by looking at the history of psychotropic drugs and their marketing: As early as the 1950s and 1960s, there was a sharp increase in prescriptions for newly discovered benzodiazepines such as Librium (chlordiazepoxide) and Valium (diazepam). These were taken primarily for their anxiety-relieving and sleep-inducing effects. By 1965, a quarter of Americans reported having tried one of these drugs.

The figure shows annual benzodiazepine production in the United States (blue bars; left scale). Production rose to over 600,000 kg during the period shown. By the mid-1960s, 25 percent of people—more than three times as many—reported having used a sedative such as Librium or Valium (red line; right scale). Data source: Parry, 1968; missing figures averaged

However, this prescribing practice came under increasing criticism. It was argued that it primarily served to sedate patients. Furthermore, the potential for dependence had been underestimated. Even today, given the now much wider range of available benzodiazepines and similar “Z-drugs,” drug dependence becomes likely after just a few weeks. Furthermore, as tolerance to the active ingredients develops, the dosage must be continually increased.

When the new serotonin enhancers were introduced to the market in the 1980s, the pharmaceutical industry wanted to explicitly distinguish them from the anti-anxiety drugs (which were criticized at the time). That is why they initially sought approval as antidepressants. It worked. But as we saw in the second part—and as professor Hasler also acknowledged above—they are not specific antidepressants at all.

United States: MAHA movement

The more general side effects of these substances have already been mentioned. In that context, I also briefly referred to the risk of sexual dysfunction associated with serotonin and norepinephrine reuptake inhibitors. The issue has now come under increased scrutiny in the U.S. thanks to Health Secretary Robert F. Kennedy Jr. In his typical, simplistic manner, he claimed that “antidepressants” are just as hard to quit as heroin.

It’s important to note that Kennedy himself was severely addicted to heroin. In 1963, his uncle, U.S. President John F., was assassinated, followed by his father, Robert F. Kennedy, in 1968. At the time, Robert F. Kennedy was a U.S. senator. According to Kennedy Jr., he began using heroin at the age of 15—that is, in 1969. It wasn’t until 14 years later, after a conviction and therapy, that he was able to quit.

In any case, his harsh criticism of „antidepressants“ is falling on fertile ground within the pharmaceutical-critical MAHA movement (Make America Healthy Again). For example, people suffering from sexual dysfunction have recently received more attention.

Sexual side effects

A prime example is Lauren Friedman, a 23-year-old student. At a MAHA conference in May, she spoke about her own experience. She said that treatment with a serotonin enhancer had left her clitoris completely numb. She also said she would not have any feelings anymore.

In fact, it has long been known that serotonin and norepinephrine enhancers can lead to sexual dysfunction. These include a decrease in sexual desire, genital numbness, delayed or complete loss of orgasm, decreased lubrication in women, and erectile dysfunction in men.

In the original studies conducted for drug approval, the incidence of such side effects was estimated to be less than 5 percent. David Healy, a British professor of psychiatry critical of the pharmaceutical industry, was involved in those studies at the time. He claims that researchers were explicitly instructed not to ask patients about sexual side effects. It is now estimated that the incidence of such side effects caused by serotonin or norepinephrine enhancers is 80 percent or even higher; this was already known in professional circles 20 years ago.

The current discussion focuses primarily on persistent sexual dysfunction that does not disappear after discontinuing the medication—or that may even first appear at that point. The first reports of this phenomenon date back to 1991, shortly after serotonin reuptake inhibitors were approved. The issue gained such prominence that a new term was coined for it: Post-SSRI Sexual Dysfunction (PSSD).

PSSD: Persistent Sexual Dysfunction

The problem is further complicated by the fact that sexual difficulties can also be part of a depressive disorder. After all, a lack of motivation and a loss of pleasure are common symptoms. Conversely, however, for some people affected, sexuality might be one of the last areas in which they experience feelings of happiness. In such cases, problems with sexual desire and erections can be devastating for people who are already struggling.

Surprisingly, studies on what these sexual side effects mean for those affected—especially when they become permanent—have only recently begun to emerge. However, these studies do not come from the field of psychiatry, where psychotropic medications are prescribed, but rather from the fields of education, psychology, and sexual medicine.

In the next part of the series, we’ll explore what this research reveals and what the medical community has recently reported on the topic of PSSD.

Warning! Changing or discontinuing psychotropic medications or their dosage may lead to adverse effects. Discuss the options and risks with your doctor in advance.

More on the Depression Epidemic

Learn more about mental disorders in Stephan Schleim’s new book: What exactly is depression and how is it diagnosed? Why are diagnoses and prescriptions constantly rising? The 27 chapters cover fundamental and current topics. Order the German book, packed with information and numerous illustrations, now for just €19.95 from the BoD Shop. Or get the eBook for just €9.99 from Amazon, Apple Books, and Google Play Books.

Sources

  • Csoka, A. B., & Shipko, S. (2006). Persistent sexual side effects after SSRI discontinuation. Psychotherapy and Psychosomatics, 75(3), 187.
  • Healy, D. (2020). Antidepressants and sexual dysfunction: a history. Journal of the Royal Society of Medicine, 113(4), 133-135.
  • Parry, H. J. (1968). Use of psychotropic drugs by US adults. Public Health Reports, 83(10), 799-810.
  • Peeples, L. (2026). The baffling science of SSRIs: how do they really work?. Nature, 656(8129), 812-814.
  • Studt, A., Gannon, M., Orzel, J., Vaughan, A., & Pearlman, A. M. (2021). Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey. International Journal of Risk & Safety in Medicine, 32(4), 321-329.

Neu: Diskutieren Sie die Blogbeiträge in der Community PsycheUndMensch auf Reddit (gratis).

Folgen Sie Stephan Schleim auf Twitter/X oder LinkedIn. Abbildung: Von WhimsicalMouse, Pixabay-Lizenz.

Avatar-Foto

Die Diskussionen hier sind frei und werden grundsätzlich nicht moderiert. Gehen Sie respektvoll miteinander um, orientieren Sie sich am Thema der Blogbeiträge und vermeiden Sie Wiederholungen oder Monologe. Bei Zuwiderhandlung können Kommentare gekürzt, gelöscht und/oder die Diskussion gesperrt werden. Nähere Details finden Sie in "Über das Blog". Dr. Stephan Schleim ist promovierter Kognitionswissenschaftler und Wissenschaftsphilosoph. Er hat an drei psychiatrischen Universitätskliniken geforscht und über 5.000 Studierende im Fach Psychologie ausgebildet, zuletzt als assoziierter Professor für theoretische Psychologie an der Universität Groningen (Niederlande). Davor war er Professor für Neurophilosophie an der Ludwig Maximilians-Universität München. Stephan Schleim kommentiert seit über 20 Jahren Entdeckungen in Psychologie, Psychiatrie und den Neurowissenschaften in den Medien. In seinem Blog "Menschen-Bilder" und zahlreichen Büchern vermittelt er einer breiten Öffentlichkeit Wissen aus diesen Fachgebieten. Sein Buch "Gehirn, Psyche und Gesellschaft: Schlaglichter aus den Wissenschaften vom Menschen" zählt über 300.000 Online-Zugriffe.

Schreibe einen Kommentar